BioSpace News Archive

Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported financial results for the third quarter ended September 30, 2021, together with other business updates.

Sight Sciences, Inc. announced that the Food and Drug Administration has granted an Investigational Device Exemption authorizing the Company to conduct a clinical study to assess the safety and effectiveness of a new, higher volume, investigational OMNI® device to perform canal viscodilation alone to lower intraocular pressure in adults with primary open-angle glaucoma.

Progenity, Inc., an innovative biotechnology company, provided a corporate update and reported financial results for the third quarter ended September 30, 2021.

Opiant Pharmaceuticals, Inc., a company advancing medicines to better treat addictions and drug overdose, announced that members of the company’s senior management team will participate in the 12th Jefferies London Healthcare Conference virtually on Thursday, November 18 and Friday, November 19.

NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy, today reported financial results for the quarter ended September 30, 2021.

RxSight, Inc.RxSight, Inc.RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, reported financial results for the three months ended September 30, 2021.

Sientra, Inc., a medical aesthetics company focused on enhancing lives by advancing the art of plastic surgery, announced its financial results for the third quarter ended September 30, 2021.

Imago BioSciences, Inc. (“Imago”) (Nasdaq: IMGO), a clinical-stage biopharmaceutical company discovering new medicines for the treatment of myeloproliferative neoplasms (MPNs), today reported financial results for the third quarter ended September 30, 2021 and highlighted recent corporate updates.

Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today reported financial results for the third quarter ended September 30, 2021 and provided a corporate update.

Heat Biologics,Inc. (“Heat”)(NASDAQ:HTBX), today provided strategic, financial, and operational updates for the third quarter ended September 30, 2021.